A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)

SK Biswas, L Gangi, S Paul, T Schioppa, A Saccani… - Blood, 2006 - ashpublications.org
SK Biswas, L Gangi, S Paul, T Schioppa, A Saccani, M Sironi, B Bottazzi, A Doni, B Vincenzo…
Blood, 2006ashpublications.org
To identify the molecular basis underlying the functions of tumor-associated macrophages
(TAMs), we characterized the gene expression profile of TAMs isolated from a murine
fibrosarcoma in comparison with peritoneal macrophages (PECs) and myeloid suppressor
cells (MSCs), using a cDNA microarray technology. Among the differentially expressed
genes, 15 genes relevant to inflammation and immunity were validated by real-time
polymerase chain reaction (PCR) and protein production. Resting TAMs showed a …
To identify the molecular basis underlying the functions of tumor-associated macrophages (TAMs), we characterized the gene expression profile of TAMs isolated from a murine fibrosarcoma in comparison with peritoneal macrophages (PECs) and myeloid suppressor cells (MSCs), using a cDNA microarray technology. Among the differentially expressed genes, 15 genes relevant to inflammation and immunity were validated by real-time polymerase chain reaction (PCR) and protein production. Resting TAMs showed a characteristic gene expression pattern with higher expression of genes coding for the immunosuppressive cytokine IL-10, phagocytosis-related receptors/molecules (Msr2 and C1q), and inflammatory chemokines (CCL2 and CCL5) as expected, as well as, unexpectedly, IFN-inducible chemokines (CXCL9, CXCL10, CXCL16). Immunohistology confirmed and extended the in vitro analysis by showing that TAMs express M2-associated molecules (eg, IL-10 and MGL1), as well as CCL2, CCL5, CXCL9, CXCL10, and CXCL16, but no appreciable NOS2. Lipopolysaccharide (LPS)-mediated activation of TAMs resulted in defective expression of several proinflammatory cytokines (eg, IL-1β, IL-6, TNF-α) and chemokines (eg, CCL3), as opposed to a strong up-regulation of immunosuppressive cytokines (IL-10, TGFβ) and IFN-inducible chemokines (CCL5, CXCL9, CXCL10, CXCL16). Thus, profiling of TAMs from a murine sarcoma revealed unexpected expression of IFN-inducible chemokines, associated with an M2 phenotype (IL-10high, IL-12low), and divergent regulation of the NF-κB versus the IRF-3/STAT1 pathway.
ashpublications.org